PolyPid (PYPD) Return on Equity [ROE] (2020 - 2026)
PolyPid's Return on Equity [ROE] came in at 446.26% for Q2 2026, up 112.33 percentage points from 333.93% a year earlier and up 105.64 percentage points from the prior quarter.
PolyPid (PYPD) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, PolyPid's Return on Equity [ROE] was 366.18%, down 669.54 percentage points from FY2024.
- Return on Equity [ROE] carries a four-year change of +444.53 percentage points (FY2021 to FY2025).
- Going back by year, Return on Equity [ROE] was 1035.72% in FY2024 (-235.48 pp), 1271.20% in FY2023 (+1460.52 pp), -189.32% in FY2022 (-110.96 pp) and -78.36% in FY2021.
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q1 2025.
- Year-over-year, Return on Equity [ROE] increased in two of the last eight quarters, with an average year-over-year change of -496.91 percentage points.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2023 (a gain of 2837.36 percentage points), and the weakest in Q4 2024 (a drop of 2702.79 percentage points).
- Business Quant data shows PYPD's Return on Equity [ROE] at 340.62% (Q1 2026), 259.39% (Q4 2025) and 189.83% (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | PolyPid | 114.87 Mn | 83.35 Mn | - | 6.65% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.65% |
| Mar 31, 2026 | 139.65% |
| Dec 31, 2025 | 108.67% |
| Sep 30, 2025 | 79.07% |
| Jun 30, 2025 | 140.87% |
| Mar 31, 2025 | 467.59% |
| Dec 31, 2024 | 332.33% |
| Sep 30, 2024 | 755.41% |
| Jun 30, 2024 | 275.14% |
| Mar 31, 2024 | 494.71% |
| Dec 31, 2023 | 1,674.48% |
| Sep 30, 2023 | 205.17% |
| Jun 30, 2023 | 159.57% |
| Mar 31, 2023 | 113.17% |
| Dec 31, 2022 | 180.12% |
| Sep 30, 2022 | 148.00% |
| Jun 30, 2022 | 97.87% |
| Mar 31, 2022 | 141.78% |
| Dec 31, 2021 | 101.96% |
| Sep 30, 2021 | 70.95% |
PolyPid Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PYPD&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PYPD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PYPD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();